1. 15 HLA-MATCHED ALLOGENEIC STEM CELL TRANSPLANTATION IMPROVES OVERALL SURVIVAL OF HIGHER RISK MYELODYSPLASTIC SYNDROME. (April 2015) Authors: Robin, M.; Porcher, R.; Ades, L.; Raffoux, E.; Michallet, M.; François, S.; Cahn, J.Y.; Delmer, A.; Wattel, E.; Vigouroux, S.; Bay, J.O.; Cornillon, J.; Huynh, A.; Nguyen, S.; Rubio, M.T.; Vincent, L.; Maillard, N.; Charbonnier, A.; de Latour, R. Peffault; Oumedaly, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Occurrence of graft‐versus‐host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT. (6th November 2017) Authors: Baron, F.; Ruggeri, A.; Beohou, E.; Labopin, M.; Mohty, M.; Sanz, J.; Vigouroux, S.; Furst, S.; Bosi, A.; Chevallier, P.; Cornelissen, J. J.; Michallet, M.; Sierra, J.; Karakasis, D.; Savani, B. N.; Gluckman, E.; Nagler, A. Journal: Journal of internal medicine Issue: Volume 283:Number 2(2018) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (FB3‐4) FLUDARABINE/BUSULFAN‐BASED CONDITIONING REGIMENS FOR NON‐HODGKIN LYMPHOMA (NHL) ALLOGRAFTED PATIENTS. (June 2017) Authors: Le Bourgeois, A.; Labopin, M.; Blaise, D.; Ceballos, P.; Vigouroux, S.; Peffault De Latour, R.; Suarez, F.; Bulabois, C.; Bay, J.; Chantepie, S.; Deconinck, E.; Daguindau, E.; Contentin, N.; Yakoub‐Agha, I.; Cornillon, J.; Francois, S.; Turlure, P.; Charbonnier, A.; Rohrlich, P.; N'Guyen, S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗